Health care leaders from various political backgrounds discussed policy priorities for the upcoming U.S. election at STAT’s Summit. Former officials from the Biden, Trump, and Obama administrations, along with industry executives, touched on topics such as Medicare, drug pricing, and artificial intelligence. Joe Grogan criticized Biden’s Inflation Reduction Act for destabilizing Medicare Part D and suggested transferring beneficiaries to Medicare Advantage. Donald Berwick emphasized the need to regulate Medicare Advantage plans to prevent overpayment. Tony Coles noted a shift towards the left for business support, while Bristol-Myers Squibb CEO Christopher Boerner shared challenges facing the industry. Micky Tripathi believes AI regulation will remain consistent regardless of the election outcome.
Source link
Election impact on health care takes center stage at STAT Summit
